Vertex Pharmaceuticals (NASDAQ:VRTX)

Bull and Bear

Top Analyst Upgrades and Downgrades: Cliffs, CME, Darden, Endo, J.C. Penney and More

Stocks were firm on Monday morning after a weak Thursday and Friday, and the question is how much Columbus Day will matter for the markets. So far, we have seen ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Apple, Alcobra, Deere, GT, J.C. Penney and More

Stocks were weak on Tuesday, but investors keep proving that they will aggressively buy overlooked or oversold stocks when they can. 24/7 Wall St. reviews dozens of brokerage firm analyst ...
Read Full Story »
Biotechnology word cloud

5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition. In the United States and the European Union, it is easier to ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: BP, Ciena, Finisar, SanDisk, VeriFone, Vertex, Wynn and More

Stocks were soft on Friday ahead of the unemployment report. Still, the markets are effectively around all-time highs, and investors remain optimistic about the U.S. recovery and are looking for ...
Read Full Story »
biotech

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

A brand new research report from RBC highlights more than 50 biotech event catalysts that are on the horizon. These are trial data, FDA decisions and company presentations coming soon. The ...
Read Full Story »
Biotechnology word cloud

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

After the biotech stocks were absolutely crushed in the late winter and early spring, many of the top firms we cover on Wall Street were aggressive in their calls to ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Abengoa Yield, CSC, Groupon, 3M, Vertex, Williams, Xerox and More

Stocks were lower again on Tuesday ahead of the unofficial launch of earnings season and after the DJIA 17,000 milestone was hit for the first time ever last week. Now ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Apple, Coach, J.C. Penney, Micron, Whole Foods, Vertex and More

It is Wednesday and stocks are trying to find their footing in mixed markets after a fresh sell-off. Investors and traders are getting used to hearing that the raging bull ...
Read Full Story »
biotech

The Real Attraction to Vertex After Cystic Fibrosis Success

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) reported Tuesday morning that two Phase 3 studies of the company's lumacaftor cystic fibrosis drug in combination with its Kalydeco ivacaftor drug showed statistically significant ...
Read Full Story »
Pills

Upcoming Binary Events Could Lift These Health Care Stocks Much Higher

Binary events in the health care arena can be huge in determining just how well investors do and their stocks perform. Medical meetings, clinical data and of, course, decisions by ...
Read Full Story »
Biotechnology word cloud

After Idenix: The Next Four Biotech Buyout Candidates

Wall Street likes nothing better than to start the week off with a bang, and pharmaceutical giant Merck & Co. Inc. (NYSE: MRK) rang the bell Monday by spending $3.85 ...
Read Full Story »
153790263

RBC Doctor Panel Picks in Drugs and Biotech

For years on Wall Street, the major firms have sought advice on stocks from people that actually use their product or work in the field of business they are analyzing. ...
Read Full Story »
dollar

These Top Stocks Are Cheap After Huge Market Sell-Off

In just a matter of days, the S&P 500 managed to produce a sell-off of more than 6%. The equity strategy team at Jefferies concede that the recent correction in ...
Read Full Story »
research

Catalysts That Could Push Top Biotech Stocks Even Higher

Despite the hard sell-off in the top biotech names last week, most Wall Street firms remain very positive on the leading stocks. The best thing about the carnage inflicted last ...
Read Full Story »
Biotechnology word cloud

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

Like many firms on Wall Street, the biotechnology team at UBS thinks that most of the top mega-cap and large cap biotech stocks are poised to beat earnings estimates across ...
Read Full Story »